AAAAAA

   
Results: 1-17 |
Results: 17

Authors: Battaglia, G Bruno, V Pisani, A Centonze, D Catania, MV Calabresi, P Nicoletti, F
Citation: G. Battaglia et al., Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission, MOL CELL NE, 17(6), 2001, pp. 1071-1083

Authors: Melchiorri, D Bruno, V Besong, G Ngomba, RT Cuomo, L De Blasi, A Copani, A Moschella, C Storto, M Nicoletti, F Lepperdinger, G Passarelli, F
Citation: D. Melchiorri et al., The mammalian homologue of the novel peptide Bv8 is expressed in the central nervous system and supports neuronal survival by activating the MAP kinase/PI-3-kinase pathways, EUR J NEURO, 13(9), 2001, pp. 1694-1702

Authors: Bruno, V Battaglia, G Copani, A Cespedes, VM Galindo, MF Cena, V Sanchez-Prieto, J Gasparini, F Kuhn, R Flor, PJ Nicoletti, F
Citation: V. Bruno et al., An activity-dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors, EUR J NEURO, 13(8), 2001, pp. 1469-1478

Authors: Bruno, V Battaglia, G Copani, A D'Onofrio, M Di Iorio, P De Blasi, A Melchiorri, D Flor, PJ Nicoletti, F
Citation: V. Bruno et al., Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs, J CEREBR B, 21(9), 2001, pp. 1013-1033

Authors: Copani, A Uberti, D Sortino, MA Bruno, V Nicoletti, F Memo, M
Citation: A. Copani et al., Activation of cell cycle-associated proteins in neuronal death: a mandatory or dispensable path?, TRENDS NEUR, 24(1), 2001, pp. 25-31

Authors: D'Onofrio, M Cuomo, L Battaglia, G Ngomba, RT Storto, M Kingston, AE Orzi, F De Blasi, A Di Iorio, P Nicoletti, F Bruno, V
Citation: M. D'Onofrio et al., Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways, J NEUROCHEM, 78(3), 2001, pp. 435-445

Authors: Milella, E Ramires, PA Brescia, E La Sala, G Di Paola, L Bruno, V
Citation: E. Milella et al., Physicochemical, mechanical, and biological properties of commercial membranes for GTR, J BIOMED MR, 58(4), 2001, pp. 427-435

Authors: Bonina, FP Arenare, L Ippolito, R Boatto, G Battaglia, G Bruno, V de Caprariis, P
Citation: Fp. Bonina et al., Synthesis, pharmacokinetics and anticonvulsant activity of 7-chlorokynurenic acid prodrugs, INT J PHARM, 202(1-2), 2000, pp. 79-88

Authors: Bruno, V Battaglia, G Ksiazek, I van der Putten, H Catania, MV Giuffrida, R Lukic, S Leonhardt, T Inderbitzin, W Gasparini, F Kuhn, R Hampson, DR Nicoletti, F Flor, PJ
Citation: V. Bruno et al., Selective activation of mGlu4 metabotropic glutamate receptors is protective against excitotoxic neuronal death, J NEUROSC, 20(17), 2000, pp. 6413-6420

Authors: Bruno, V Ksiazek, I Battaglia, G Lukic, S Leonhardt, T Sauer, D Gasparini, F Kuhn, R Nicoletti, F Flor, PJ
Citation: V. Bruno et al., Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective, NEUROPHARM, 39(12), 2000, pp. 2223-2230

Authors: Bruno, V Copani, A Besong, G Scoto, G Nicoletti, F
Citation: V. Bruno et al., Neuroprotective activity of chemokines against N-methyl-D-aspartate or beta-amyloid-induced toxicity in culture, EUR J PHARM, 399(2-3), 2000, pp. 117-121

Authors: Battaglia, G La Russa, M Bruno, V Arenare, L Ippolito, R Copani, A Bonina, F Nicoletti, F
Citation: G. Battaglia et al., Systemically administered D-glucose conjugates of 7-chlorokynurenic acid are centrally available and exert anticonvulsant activity in rodents, BRAIN RES, 860(1-2), 2000, pp. 149-156

Authors: Ciccarelli, R Di Iorio, P Bruno, V Battaglia, G D'Alimonte, I D'Onofrio, M Nicoletti, F Caciagli, F
Citation: R. Ciccarelli et al., Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100 beta protein from cultured astrocytes, GLIA, 27(3), 1999, pp. 275-281

Authors: Bruno, V Battaglia, G Kingston, A O'Neill, MJ Catania, MV Di Grezia, R Nicoletti, F
Citation: V. Bruno et al., Neuroprotective activity of the potent and selective mGlula metabotropic glutamate receptor antagonist, (+)-2-methyl-4 caroxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlula and mGlu5 receptors, NEUROPHARM, 38(2), 1999, pp. 199-207

Authors: Nicoletti, F Bruno, V Catania, MV Battaglia, G Copani, A Barbagallo, G Cena, V Sanchez-Prieto, J Spano, PF Pizzi, M
Citation: F. Nicoletti et al., Group-I metabotropic glutamate receptors: hypotheses to explain their dualrole in neurotoxicity and neuroprotection, NEUROPHARM, 38(10), 1999, pp. 1477-1484

Authors: Gasparini, F Bruno, V Battaglia, G Lukic, S Leonhardt, T Inderbitzin, W Laurie, D Sommer, B Varney, MA Hess, SD Johnson, EC Kuhn, R Urwyler, S Sauer, D Portet, C Schmutz, M Nicoletti, F Flor, PJ
Citation: F. Gasparini et al., (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo, J PHARM EXP, 289(3), 1999, pp. 1678-1687

Authors: Bruno, V Battaglia, G Copani, A Casabona, G Storto, M Gerevini, VD Ngomba, R Nicoletti, F
Citation: V. Bruno et al., Metabotropic glutamate receptors and neurodegeneration, PROG BRAIN, 116, 1998, pp. 209-221
Risultati: 1-17 |